Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
78,411,033
-
Number of holders
-
130
-
Total 13F shares, excl. options
-
57,878,556
-
Shares change
-
-855,195
-
Total reported value, excl. options
-
$278,395,526
-
Value change
-
-$5,016,357
-
Put/Call ratio
-
5.5%
-
Number of buys
-
79
-
Number of sells
-
42
-
Price
-
$4.81
Institutional Holders of Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR) as of Q4 2022
As of 31 Dec 2022 Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR) had 153 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 57,878,556 shares of stock of the company.
Largest 10 holders included FMR LLC, BlackRock Inc., EcoR1 Capital, LLC, VANGUARD GROUP INC, FEDERATED HERMES, INC., Bain Capital Life Sciences Investors, LLC, STATE STREET CORP, Cormorant Asset Management, LP, GEODE CAPITAL MANAGEMENT, LLC, and Tyrus Capital S.A.M..
This table shows 153 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.